9 Tips for Navigating the Inevitable Unexpected
Michael McKinney
MARCH 12, 2024
If sophisticated investors are involved — as often happens in biotech — the plan is undoubtedly subjected to intensive due diligence. Some fail for a host of strategic or operational shortcomings addressed in any decent business school course. No question the biotech industry is experiencing significant growth.
Let's personalize your content